Abstract

Forced Degradation of an EphA2-Antibody Directed Nanotherapeutic Incorporating a Novel Docetaxel Prodrug

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call